Omada Health, Inc. - 8-K Filing

Omada Health reported Q1 2026 revenue of $78 million, up 42% year-over-year, with total members reaching 1.02 million, a 51% increase. The company achieved a gross margin of 62% and adjusted EBITDA of $1 million, compared to a $4 million loss in Q1 2025. It also expanded its partnerships to include all three leading pharmacy benefit managers (PBMs). For 2026, Omada expects revenue between $322 million and $330 million and adjusted EBITDA between $14 million and $20 million. (Items: 2.02 Results of Operations and Financial ConditionOn May 7, 2026, Omada Health, Inc, 9.01 Financial Statements and Exhibits(d) Exhibits)

SEC EDGAR ·

Tickers: $OMDA

Read the full article at SEC EDGAR

More Regulatory news